Safety and Tolerability of Research Lumbar Puncture in Huntington Disease: the HDClarity Cohort and Community Bioresource

被引：0
|
作者：
Rodrigues, Filipe B. [1 ]
Ehrhardt, Anka [2 ]
Owen, Gail [1 ]
Gosling, Stef [1 ]
Lifer, Sherry [2 ]
Neacy, Eileen [2 ]
Kaur, Dipinder [2 ]
Handley, Olivia [2 ,3 ]
Townhill, Jenny [2 ,3 ]
Leavitt, Blair [4 ]
Guttman, Mark [5 ]
Bang, Jee [6 ]
Levey, Jamie [2 ,6 ]
Pak, Elena [2 ]
Sampaio, Cristina [2 ]
Wild, Edward J. [1 ]
机构：
[1] UCL Queen Sq Inst Neurol, UCL Huntingtons Dis Ctr, London, England
[2] CHDI Fdn, CHDI Management, Princeton, NJ USA
[3] Univ Hosp Ulm, European Huntingtons Dis Network, Ulm, Germany
[4] Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[5] Univ Toronto, Div Neurol, Dept Med, Toronto, ON, Canada
[6] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
来源：
NEUROTHERAPEUTICS | 2018年 / 15卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
8
引用
收藏
页码：1171 / 1171
页数：1
相关论文
共 50 条
  • [31] Safety and Tolerability of Tolvaptan in an Autosomal Dominant Polycystic Kidney Disease Spanish Cohort: A Real-World Experience
    Guerra-Torres, Xavier E.
    Pena Esparragoza, J.
    Perez Fernandez, M.
    Fernandez Rodriguez, M.
    Mancha Ramos, J.
    Martinez Miguel, P.
    Rodriguez Puyol, D.
    Bouarich, H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [32] WHEN THEY HEAR WHAT WE SAY: ETHICAL CHALLENGES IN PRESENTING RESEARCH FINDINGS TO THE HUNTINGTON DISEASE COMMUNITY
    Bombard, Yvonne
    Cox, Susan M.
    Semaka, Alicia
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2011, 6 (03) : 47 - 54
  • [33] A retrospective observational cohort study of the anesthetic management and outcomes of pediatric patients with Alexander disease undergoing lumbar puncture or magnetic resonance imaging
    Berger, Jessica A.
    Simpao, Allan F.
    Dubow, Scott R.
    McClung, Heather A.
    Liu, Geraldine W.
    Waldman, Amy T.
    Drum, Elizabeth T.
    PEDIATRIC ANESTHESIA, 2024, 34 (08) : 810 - 817
  • [34] LONG-TERM SAFETY AND TOLERABILITY OF PRIDOPIDINE IN PATIENTS WITH HUNTINGTON'S DISEASE (HD): RESULTS OF THE MERMAIHD STUDY OPEN-LABEL EXTENSION
    Squitieri, F.
    Landwehrmeyer, B.
    Reilmann, R.
    Rosser, A.
    Garcia de Yebenes, J.
    Prang, A.
    Ivkovic, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 : A56 - A57
  • [35] SAFETY AND TOLERABILITY OF ONE-HOUR INFLIXIMAB INFUSION IN INFLAMMATORY BOWEL DISEASE PATIENTS: A PROSPECTIVE OBSERVATIONAL COHORT STUDY
    Mazzuoli, S.
    Di Molfetta, A.
    Rizzi, M.
    Regano, N.
    Gatti, F.
    Losito, F.
    Guglielmi, F. W.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E132 - E132
  • [36] Safety and Tolerability of Comprehensive Research Bronchoscopy in Chronic Obstructive Pulmonary Disease Results from the SPIROMICS Bronchoscopy Substudy
    Wells, J. Michael
    Arenberg, Douglas A.
    Barjaktarevic, Igor
    Bhatt, Surya P.
    Bowler, Russell P.
    Christenson, Stephanie A.
    Couper, David J.
    Dransfield, Mark T.
    Han, MeiLan K.
    Hoffman, Eric A.
    Kaner, Robert J.
    Kim, Victor
    Kleerup, Eric
    Martinez, Fernando J.
    Moore, Wendy C.
    O'Beirne, Sarah L.
    Paine, Robert, III
    Putcha, Nirupama
    Raman, Sanjeev M.
    Barr, R. Graham
    Rennard, Stephen, I
    Woodruff, Prescott G.
    Curtis, Jeffrey L.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (04) : 439 - 446
  • [37] SAFETY AND TOLERABILITY OF SELISISTAT FOR THE TREATMENT OF HUNTINGTON'S DISEASE: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II TRIAL
    Reilmann, R.
    Squitieri, F.
    Priller, J.
    Saft, C.
    Mariotti, C.
    Suessmuth, S. D.
    Nemeth, A. H.
    Tabrizi, S. J.
    Quarrell, O.
    Craufurd, D.
    Rickards, H.
    Rosser, A.
    Darpo, B.
    Tessari, M.
    Szynol, A.
    Fischer, D. F.
    Frost, C.
    Farmer, R. E.
    Landwehrmeyer, G. B.
    Westerberg, G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 : A102 - A102
  • [38] Efficacy, Safety, and Tolerability of Pridopidine in Huntington's disease (HD): Results From the Phase II Dose-Ranging Study, Pride-HD
    Reilmann, R.
    McGarry, A.
    Landwehrmeyer, G.
    Kieburtz, K.
    Grachev, I.
    Eyal, E.
    Savola, J.
    Borowsky, B.
    Papapetropoulos, S.
    Hayden, M.
    MOVEMENT DISORDERS, 2017, 32
  • [39] Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
    Angus, D.
    Herd, C.
    Stone, C.
    Stout, J.
    Wieler, M.
    Reilmann, R.
    Ritchie, C. W.
    Dorsey, E. R.
    Helles, K.
    Kayson, E.
    Oakes, D.
    Rosas, H. D.
    Vaughan, C.
    Panegyres, P. K.
    Ames, D.
    Goh, A.
    Agarwal, P.
    Churchyard, A.
    Murathodizic, M.
    Chua, P.
    Germaine, D.
    Lim, L.
    Mack, H.
    Loy, C.
    Griffith, J.
    Mitchell, P.
    Corey-Bloom, J.
    Gluhm, S.
    Goldstein, J.
    Levi, L.
    Margolis, R.
    Yoritomo, N.
    Janicki, S.
    Marder, K.
    Clouse, R.
    Singer, C.
    Moore, H.
    Padron, N.
    Kostyk, S.
    Daley, A.
    Segro, V.
    Kumar, R.
    Anderson, K.
    Drazinic, C.
    Hennig, B.
    Nance, M.
    Molho, E.
    Criswell, S.
    LeDoux, M. S.
    Guyot, S.
    LANCET NEUROLOGY, 2015, 14 (01): : 39 - 47
  • [40] STEADY-PD. Safety and tolerability of isradipine CR in patients with early Parkinson's disease. Baseline characteristics of the cohort
    Simuni, T.
    Biglan, K.
    Deeley, C.
    Gardiner, I.
    Oakes, D.
    MOVEMENT DISORDERS, 2011, 26 : S140 - S140
12345